Acta Scientific Microbiology

Research Article Volume 7 Issue 8

In-silico Studies of Jatropha curcas Bioactive Compounds as Anti SARS-CoV-2

Saeful Amin1*, Widia Danisa Nurul Huda1, Winda Trisna Wulandari1 and Salsabila Adlina2

1Department of Pharmacy, Bakti Tunas Husada University, Indonesia
2Department of Pharmacy, Perjuangan University, Indonesia

*Corresponding Author:Saeful Amin, Department of Pharmacy, Bakti Tunas Husada University, Indonesia.

Received: June 11, 2024; Published: July 20, 2024

Abstract

COVID-19 is a disease caused by Coronavirus a new type Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) which includes a disease outbreak that began at the end of December 2019 marked by a mysterious pneumonia case of unknown etiology, starting in Wuhan, China which until now it is still a concern and has not experienced a termination of the case. Jatropha curcas L. has several secondary metabolites that have antiviral activity which can be a potential antiviral therapy for SARS-CoV-2. The purpose of this study was to determine the compounds contained in the Jatropha plant and the interactions that occur in inhibiting SARS-CoV-2 by molecular docking and molecular dynamic. The results showed that the compounds rhoifolin and stellarin-2 had physicochemical properties with large molecular weights and good pharmacokinetics and toxicity. Results docking score docking was -94.8779 against the 5R7Y receptor and then -108.2190 for stellarin-2 to the 7TLL receptor and had good stability in molecular dynamics compared to native ligands and Molnupiravir for comparison. The interactions formed were 6 hydrogen bonds in rhoifolin and 7 hydrogen bonds in stellarin-2. This shows that rhoifolin and stellarin-2 have potential as anti-SARS-CoV-2 candidates.

Keywords: Jatropha; Molecular Docking; Molecular Dynamic; Rhoifolin; SARS-CoV-2; Stellarin-2

References

  1. Agrawal A., et al. “Jatropha curcas plant as Antiviral agent and as a Biodesel”. International Journal of Pharmacy and Life Sciences 3 (2020): 6516-6519.
  2. Bimonte S., et al. “Potential antiviral drugs for SARS-Cov-2 treatment: Preclinical findings and ongoing clinical research”. In Vivo 34 (2020): 1597-1602.
  3. Chemairs (2019).
  4. Dahake R., et al. “Potential Anti-HIV activity of Jatropha curcas Linn. Leaf extracts”. Journal of Antivirals and Antiretrovirals 7 (2013): 160-165.
  5. Ghosh AK., et al. “Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies”. Journal of Medicinal Chemistry 19 (2021): 14702-14714.
  6. Hariz MF. “Uji Sitotoksik, Toksisitas, dan Prediksi Sifat Fisikokimia Senyawa Isoliquiritigenin dan Oxyresveratrol Terhadap Reseptor B-Sel Lymphoma 2 (4AQ3) dan Vaskular Endotelia Growth Factor Reseptor-2 (2RL5) Sebagai Terapi Kanker Servic Secara In Silico”. Universitas Islam Negeri Malang (2019).
  7. Herawati IE., et al. “Prediction Of Anticancer Activity Of Ricin-A Through Autophagy Pathway Using Molecular Docking On Beclin-1, LC3, and p62”. Jurnal Ilmiah Farmako Bahari Journal1 (2022): 22-30.
  8. Indrawijaya YYA., et al. “Cytotoxic Activity and Physicochemical Propreties Of Gendarusin A-E Compounds On Estrogen Alfa Receptors (2JF9)”. Journal of Islamic Pharmacy1 (2020): 56-64.
  9. Krihariyani D., et al. “Studi Insilico Aktivitas Antioksidan dan ADMET Brazilein Kayu Secang (Caesalpinia sappan L.) terhadap Escherichia Coli Extended Spectrum BetaLactamase (ESBL)”. Prosiding Seminar Nasional Kesehatan (2019): 251-257.
  10. Kumar T R., et al. “Experimental Investigation on the Performance of a Solar Still Using SiO2 Nanoparticles /Jatropha curcas L”. Silicon (2021).
  11. Lestari T. “Studi Interaksi Senyawa Turunan 1 , 3-Dibenzoiltiourea sebagai Ribonukleotida Reduktase Inhibitor”. Jurnal Farmasi Indonesia3 (2015): 163-169.
  12. Lipinski CA. “Lead- and drug-like compounds: The rule-of-five revolution”. Drug Discovery Today: Technologies4 (2004): 337-341.
  13. Liu K and Kokubo H. “Exploring the Stability of Ligand Binding Modes to Proteins by Molecular Dynamics Simulations: A Cross-docking Study”. Journal of Chemical Information and Modeling10 (2017): 2514-2522.
  14. Dermawan D., et al. “Molecular Dynamics Simulation of Estrogen Receptor Alpha Against Andrografolid as Anti Breast Cancer” 6.2 (2019): 65-76.
  15. Patil D., et al. “Evaluation of Jatropha curcas Linn. leaf extracts for its cytotoxicity and potential to inhibit hemagglutinin protein of influenza virus”. Indian Journal of Virology2 (2013): 220-226.
  16. Pires DEV., et al. “pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures”. Journal of Medicinal Chemistry9 (2015): 4066-4072.
  17. Rachmania Arcinthya R and Prof. Dr. Hamka. “Validasi Protokol Skrining Virtual dan Analisis Interaksi Inhibitor Antiproliferasi Sel Kanker Berbasis Bahan Alam Terhadap Reseptor Cyclin-Dependent Kinase 4 (CDK 4)”. Media Farmasi1 (2019): 21-40.
  18. Rothan H A and Byrareddy S N. “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak”. Journal of Autoimmunity 109 (2020): 102433.
  19. Ruswanto R., et al. “Kuersetin, Penghambat Uridin 5-Monofosfat Sintase Sebagai Kandidat Anti-kanker”. ALCHEMY Jurnal Penelitian Kimia2 (2018): 236-252.
  20. Ruswanto R., et al. “Desain dan Studi In Silico Senyawa Turunan Kuwanon-H sebagai Kandidat Obat Anti-HIV”. Jurnal Kimia VALENSI1 (2020): 57-66.
  21. Tallei TE., et al. “Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study”. Scientifica (2020).
  22. Vinchurkar A S., et al. “Screening for Larvicidal Activity of Jatropha curcas”. Open Access International Journal of Science and Engineering12 (2017): 14-16.

Citation

Citation: Saeful Amin., et al. “In-silico Studies of Jatropha curcas Bioactive Compounds as Anti SARS-CoV-2".Acta Scientific Microbiology 7.8 (2024): 53-69.

Copyright

Copyright: © 2024 Saeful Amin., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US